Form 4: CONMED CFO Receives Stock Grant
Insider Transaction (Form 4)
John E Gallagher, Executive Vice President & CFO of CONMED Corp, reported multiple transactions in common stock on July 15, 2026.
Summary
- Grant/award: acquired 35,054 RSUs (Restricted Stock Units) on July 15, 2026; holds 35,054 after (Direct).
- Grant/award: acquired 26,875 RSUs (Restricted Stock Units) on July 15, 2026; holds 61,929 after (Direct).
- Grant/award: acquired 30,536 Options To Purchase Common Stock on July 15, 2026; holds 30,536 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John E Gallagher — Officer (Executive Vice President & CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Grant/award | RSUs (Restricted Stock Units) | 35,054 | — | — | 35,054 |
| 2026-07-15 | Grant/award | RSUs (Restricted Stock Units) | 26,875 | — | — | 61,929 |
| 2026-07-15 | Grant/award | Options To Purchase Common Stock | 30,536 | — | — | 30,536 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Grant/award (35,054 shares) |
| 2026-07-15 | Grant/award (26,875 shares) |
| 2026-07-15 | Grant/award (30,536 shares) |
Keywords
insider transaction, Form 4, CNMD, CONMED Corp, neutral, John E Gallagher
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.